Hep C Flashcards
Hep C Infections
Acute or chronic. Acute is self-limiting. Chronic is progressive to liver failure over decades. Co-infection with Hep B and HIV are common; more rapid progression. Hep B can be reactivated while treating Hep C
Treatment Overview
Antiviral Therapy; Hep C can be eliminated.
Dose adjustments only after the disease progresses.
Vaccinations are important.
Goal: Eradicate HCV RNA to an undetectable level 12 wks after treatment completion; Sustained Virologic Response (SVR).
Regimen selection depends on genotype of HCV, co-infections, etc
Overview of Agents
Protease Inhibitors
NS5A Inhibitors
NNPI
NS5B Polymerase Inhibitors
Preferred Regimens
G/P 8 wks
L/S 12 wks
S/V 12 wks
Glecaprevir/Pibrentasvir
Mavyret
IND: Chronic Hep C
MOA: G: Protease inhibitor; inhibits viral replication.
P: NS5A inhibitor; inhibits viral RNA replication inhibitor and viral assembly
BOX: Hep B reactivation
CON: Mod-severe hepatic impairment, Hx of hepatic decompensation, use with Atazanavir or Rifampin
ADR: Nausea, fatigue, HA
Ledipasvir/Sofosbuvir
Harvoni
IND: Chronic Hep C
MOA: L: NS5A inhibitor
S: NS5B inhibitor; inhibits viral replication
BOX: Hep B reactivation
CON: n/a
ADR: HA, fatigue, asthenia
Sofosbuvir/Velpatasvir
Epclusa
IND: Chronic Hep C
MOA: NS5B and NS5A
BOX: Hep B
CON: n/a
ADR: fatigue, HA
Elbasvir/Grazoprevir
Zepatier
IND: Chronic Hep C
MOA: HS5A inhibitor and G-protease inhibitor
BOX: Hep B
CON: Hepatic impairment, Hx of hepatic decompensation, use with OATP1B1/3 inhibitors and CYP3A4 inducers; ALWAYS use a DI checker
ADR: fatigue
Monitoring Therapy
To check for viral resistance and adherence issues.
Checked at wk 4, re-check at wk 6. Too high at 6, switch therapies
Check SVR at 12 wks and 24 wks POST-d/c
Does not confer immunity to HCV, can be reinfected
Ribavirin
OLD and SUCK
IND: Chronic Hep C
MOA: Inhibit RNA replication
BOX: Hemolytic anemia; may result in worsening cardiac dz (potentially fatal)
Pregnancy-Teratogenic and embryocidal
CON: Pregnancy, severe renal impairment, hepatic impairment
ADR: Tons of ADRs